Identify exactly what is being offered
Ask for the product name, source, preparation method and route of administration. Clarify whether it is taken from your own body or a donor, whether it is modified or processed and which organization supplies it. A verbal explanation should be supported by a written treatment description.
If the clinic uses a package name, request the individual components. Different products and methods cannot be treated as equivalent merely because they appear under the same regenerative medicine label.
Ask for evidence for your specific condition
Request studies relevant to the exact treatment and the problem you want addressed. Ask whether the research compares outcomes with an alternative or a control group, how many patients were followed and how long they were observed. A laboratory finding or a testimonial does not answer the same question as a clinical study.
Ask what improvement the doctor reasonably expects for you and how it will be measured. Broad claims about immunity, anti-aging or general wellness need a clear clinical meaning before you can judge whether treatment is worthwhile.
Clarify regulatory status in the place of treatment
Ask the clinic to identify the applicable Korean authorization or legal pathway for the exact product and intended use. If it is research, request the study registration, ethics information and participant documentation. Do not assume that a product’s status in one country establishes its status in another.
FDA consumer information warns about unapproved regenerative products and reported serious harms in the United States. That warning is a reason to ask precise questions; it is not a substitute for checking Korean requirements or the specific proposal you receive.
Discuss harms and alternatives explicitly
Ask about known adverse effects, important unknowns and the process for managing complications. A treatment derived from your own tissue is not automatically risk-free. Ask whether receiving it could delay or complicate established care for your condition.
Compare the proposal with evidence-based alternatives and with choosing no intervention at present. If you have a serious diagnosis, discuss the plan with a clinician familiar with that condition before changing existing treatment.
Understand follow-up and financial commitments
Ask how long follow-up lasts, which tests or reviews are planned and what happens if there is no improvement. Clarify whether repeat sessions are being proposed and what evidence supports that schedule. Request a written cost breakdown and avoid assuming that payment indicates an established benefit.
Before agreeing, you should be able to name the treatment, explain the evidence and uncertainty, identify its local regulatory basis and describe the follow-up plan. If the clinic cannot provide those answers clearly, pause the decision and seek an independent assessment.
Recognize when the description is still too vague
A proposal is not ready for an informed decision if it cannot move beyond broad phrases such as activate your cells or restore youth. Ask the clinician to replace those phrases with a measurable outcome, a defined treatment and evidence for that use. If the explanation changes each time you ask, request a written summary before proceeding.
Be cautious about using unrelated approvals or research as reassurance. A study of one cell product in one condition does not establish benefit for a different product, route or purpose. Ask the doctor to explain the connection rather than assuming that the shared word stem cell makes the evidence transferable.
If research participation is proposed, distinguish the aims of a study from a promise of personal benefit. Ask about alternatives, costs, withdrawal, follow-up and how unexpected problems are reported and managed. An independent specialist can help you assess whether the proposal fits your medical situation. Keeping the decision focused on the specific intervention protects you from being persuaded by the broad appeal of a scientific field whose individual applications can have very different evidence and risk profiles.
Keep the evidence discussion separate from clinic hospitality or convenience. Excellent coordination can make a visit easier, but it cannot establish whether the proposed biological treatment will help your condition.